TRDA – entrada therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Entrada Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Entrada Therapeutics (TRDA) was upgraded by Wall Street Zen from "sel
Entrada Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results [Yahoo! Finance]
Entrada Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results
Entrada Therapeutics (NASDAQ:TRDA) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $20.00 price target on the stock.
Form 144 Entrada Therapeutics, Filed by: WENTWORTH KORY JAMES
Form 4 Entrada Therapeutics, For: Mar 01 Filed by: WENTWORTH KORY JAMES
Form 4 Entrada Therapeutics, For: Mar 01 Filed by: Doshi Dipal
Form 4 Entrada Therapeutics, For: Mar 01 Filed by: Dowden Nathan J
Form 4 Entrada Therapeutics, For: Mar 01 Filed by: Sethuraman Natarajan
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.